These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 23038420)

  • 1. Cognitive impairment in Parkinson's disease: the dual syndrome hypothesis.
    Kehagia AA; Barker RA; Robbins TW
    Neurodegener Dis; 2013; 11(2):79-92. PubMed ID: 23038420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease.
    Goldman JG; Ghode RA; Ouyang B; Bernard B; Goetz CG; Stebbins GT
    Parkinsonism Relat Disord; 2013 Sep; 19(9):806-11. PubMed ID: 23735187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild cognitive impairment in Parkinson's disease.
    Aarsland D; Brønnick K; Fladby T
    Curr Neurol Neurosci Rep; 2011 Aug; 11(4):371-8. PubMed ID: 21487730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive deficits in Parkinson's disease: a cognitive neuroscience perspective.
    Robbins TW; Cools R
    Mov Disord; 2014 Apr; 29(5):597-607. PubMed ID: 24757109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive and behavioral disorders in Parkinson's disease: an update. I: cognitive impairments.
    Papagno C; Trojano L
    Neurol Sci; 2018 Feb; 39(2):215-223. PubMed ID: 29043468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study.
    Nombela C; Rowe JB; Winder-Rhodes SE; Hampshire A; Owen AM; Breen DP; Duncan GW; Khoo TK; Yarnall AJ; Firbank MJ; Chinnery PF; Robbins TW; O'Brien JT; Brooks DJ; Burn DJ; ; Barker RA
    Brain; 2014 Oct; 137(Pt 10):2743-58. PubMed ID: 25080285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cognitive impairment in Parkinson's disease].
    Tachibana H
    Seishin Shinkeigaku Zasshi; 2013; 115(11):1142-9. PubMed ID: 24450147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.
    Christopher L; Marras C; Duff-Canning S; Koshimori Y; Chen R; Boileau I; Segura B; Monchi O; Lang AE; Rusjan P; Houle S; Strafella AP
    Brain; 2014 Feb; 137(Pt 2):565-75. PubMed ID: 24334314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease.
    Pagonabarraga J; Kulisevsky J; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A
    Mov Disord; 2008 May; 23(7):998-1005. PubMed ID: 18381647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficit in specific cognitive domains associated with dementia in Parkinson's disease.
    Pal A; Pegwal N; Kaur S; Mehta N; Behari M; Sharma R
    J Clin Neurosci; 2018 Nov; 57():116-120. PubMed ID: 30150061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease-related disorders in the impulsive-compulsive spectrum.
    Wolters ECh; van der Werf YD; van den Heuvel OA
    J Neurol; 2008 Sep; 255 Suppl 5():48-56. PubMed ID: 18787882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment and dementia in Parkinson's disease.
    Pagonabarraga J; Kulisevsky J
    Neurobiol Dis; 2012 Jun; 46(3):590-6. PubMed ID: 22484304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease.
    Weintraub D; Simuni T; Caspell-Garcia C; Coffey C; Lasch S; Siderowf A; Aarsland D; Barone P; Burn D; Chahine LM; Eberling J; Espay AJ; Foster ED; Leverenz JB; Litvan I; Richard I; Troyer MD; Hawkins KA;
    Mov Disord; 2015 Jun; 30(7):919-27. PubMed ID: 25737166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Neuropsychological Profile of Mild Cognitive Impairment in Lewy Body Dementias.
    Ciafone J; Little B; Thomas AJ; Gallagher P
    J Int Neuropsychol Soc; 2020 Feb; 26(2):210-225. PubMed ID: 31826772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease.
    Siepel FJ; Brønnick KS; Booij J; Ravina BM; Lebedev AV; Pereira JB; Grüner R; Aarsland D
    Mov Disord; 2014 Dec; 29(14):1802-8. PubMed ID: 25284687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognition in Parkinson's Disease.
    O'Callaghan C; Lewis SJG
    Int Rev Neurobiol; 2017; 133():557-583. PubMed ID: 28802933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attentional control in Parkinson's disease is dependent on COMT val 158 met genotype.
    Williams-Gray CH; Hampshire A; Barker RA; Owen AM
    Brain; 2008 Feb; 131(Pt 2):397-408. PubMed ID: 18178571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Executive functioning and risk-taking behavior in Parkinson's disease patients with impulse control disorders.
    Pineau F; Roze E; Lacomblez L; Bonnet AM; Vidailhet M; Czernecki V; Corvol JC
    J Neural Transm (Vienna); 2016 Jun; 123(6):573-81. PubMed ID: 27085342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder.
    Drew DS; Muhammed K; Baig F; Kelly M; Saleh Y; Sarangmat N; Okai D; Hu M; Manohar S; Husain M
    Brain; 2020 Aug; 143(8):2502-2518. PubMed ID: 32761061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impulse control disorders in Parkinson's disease.
    Weintraub D; Potenza MN
    Curr Neurol Neurosci Rep; 2006 Jul; 6(4):302-6. PubMed ID: 16822350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.